Literature DB >> 9679793

Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty.

R H White1, P S Romano, H Zhou, J Rodrigo, W Bargar.   

Abstract

BACKGROUND: Little is known about the incidence and time course of clinical thromboembolic events after total hip or knee arthroplasty, particularly after hospital discharge.
METHODS: We used a linked hospital discharge database provided by the State of California to identify cases diagnosed as having deep vein thrombosis or pulmonary embolism within 3 months of unilateral total hip or knee arthroplasty. Also, we surveyed orthopedic surgeons to estimate the frequency of postoperative thromboprophylaxis during July 1991 through June 1993. Medical charts were audited to determine the accuracy of the coded records.
RESULTS: Among 19,586 primary hip and 24,059 primary knee arthroplasties, the cumulative incidence of deep vein thrombosis or pulmonary embolism within 3 months of surgery was 556 (2.8%) after hip arthroplasty and 508 (2.1%) after knee arthroplasty. The diagnosis of thromboembolism was made after hospital discharge in 76% and 47% of the total hip and total knee arthroplasty cases, respectively (P<.001), with a median time of diagnosis of 17 days and 7 days after surgery, respectively (P<.001). Questionnaire results indicated that 95% of all cases received thromboprophylaxis and that the frequency, type, and duration of thromboprophylaxis was virtually identical after hip and knee arthroplasty.
CONCLUSIONS: There is a difference in the temporal patterns of clinically symptomatic thromboembolic complications after total hip and total knee arthroplasty, suggesting differences in pathogenesis or natural history. The findings suggest that to further reduce thromboembolic outcomes, earlier, more intense prophylaxis may be needed for total knee arthroplasty, and more prolonged prophylaxis may be required after total hip arthroplasty.

Entities:  

Mesh:

Year:  1998        PMID: 9679793     DOI: 10.1001/archinte.158.14.1525

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  89 in total

Review 1.  A guide to venous thromboembolism risk factor assessment.

Authors:  G D Motykie; L P Zebala; J A Caprini; C E Lee; J I Arcelus; J J Reyna; E B Cohen
Journal:  J Thromb Thrombolysis       Date:  2000-04       Impact factor: 2.300

2.  Costs and outcomes of hip fracture and stroke, 1984 to 1994.

Authors:  F A Sloan; D H Taylor; G Picone
Journal:  Am J Public Health       Date:  1999-06       Impact factor: 9.308

3.  Value-of-information analysis to reduce decision uncertainty associated with the choice of thromboprophylaxis after total hip replacement in the Irish healthcare setting.

Authors:  Laura McCullagh; Cathal Walsh; Michael Barry
Journal:  Pharmacoeconomics       Date:  2012-10-01       Impact factor: 4.981

4.  Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Yngve Falck-Ytter; Charles W Francis; Norman A Johanson; Catherine Curley; Ola E Dahl; Sam Schulman; Thomas L Ortel; Stephen G Pauker; Clifford W Colwell
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

5.  Retrospective analysis of adherence to thromboprophylaxis after orthopedic surgery in a community hospital.

Authors:  Megan A McElwee; Aaron Tejani; Lily Cheng
Journal:  Can J Hosp Pharm       Date:  2010-03

6.  Incidence of venous thromboembolism after bariatric surgery: a population-based cohort study.

Authors:  David A Froehling; Paul R Daniels; Karen F Mauck; Maria L Collazo-Clavell; Aneel A Ashrani; Michael G Sarr; Tanya M Petterson; John A Heit
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

Review 7.  The true treatment benefit is unpredictable in clinical trials using surrogate outcome measured with diagnostic tests.

Authors:  Behrouz Kassaï; Nirav R Shah; Alain Leizorovicza; Michel Cucherat; Francois Gueyffier; Jean-Pierre Boissel
Journal:  J Clin Epidemiol       Date:  2005-10       Impact factor: 6.437

8.  Preoperative status and risk of complications in patients with hip fracture.

Authors:  Mary Ann McLaughlin; Gretchen M Orosz; Jay Magaziner; Edward L Hannan; Thomas McGinn; R Sean Morrison; Tsivia Hochman; Kenneth Koval; Marvin Gilbert; Albert L Siu
Journal:  J Gen Intern Med       Date:  2005-12-22       Impact factor: 5.128

9.  High incidence of deep venous thrombosis after Achilles tendon rupture: a prospective study.

Authors:  Katarina Nilsson-Helander; Anders Thurin; Jon Karlsson; Bengt I Eriksson
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2009-02-24       Impact factor: 4.342

Review 10.  The use of novel oral anticoagulants for thromboprophylaxis after elective major orthopedic surgery.

Authors:  Saleh Rachidi; Ehab Saad Aldin; Charles Greenberg; Barton Sachs; Michael Streiff; Amer M Zeidan
Journal:  Expert Rev Hematol       Date:  2013-12       Impact factor: 2.929

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.